A rare cause of diarrhoea: uncommon effect of an ordinary medication

Bibliographic Details
Main Author: Costa, Rafaela
Publication Date: 2022
Other Authors: Cunha, Maria João
Format: Article
Language: por
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: https://doi.org/10.32385/rpmgf.v38i5.13360
Summary: Introduction: Arterial hypertension is a chronic condition and one of the main risk factors for cardiovascular disease. Therefore, patients presenting with this disorder benefit from regular follow-ups with their general practitioner/family doctor (FD). Blood pressure control can be achieved with lifestyle measures alone or by resorting simultaneously to pharmacological treatment. Among pharmacological options, angiotensin II receptor blockers (ARB) stand out for being commonly used due to their anti-hypertensive effect and safety profile, albeit they can rarely cause severe chronic diarrhoea. This case report intends to present a rare diagnosis and sharpen FD to a new diagnostic hypothesis in the face of chronic diarrhoea. Case report: A 65-year-old woman, with a personal history of arterial hypertension treated with olmesartan 20mg since 2012 and no other relevant personal history. The patient presented with a one-month history of diarrhoea entailing several medical evaluations. Along with abdominal pain, nausea, vomiting, asthenia, and weight loss. Due to an inconclusive outpatient investigation and lack of clinical response to the multiple empirical treatments, the patient was proposed for hospital admission for further etiological study. While hospitalized, olmesartan was discontinued resulting in symptom resolution, which lead to patient discharge with the diagnosis of sprue-like enteropathy. Conclusion: This case intends to emphasize the importance of a complete and detailed medical history, recall the main steps in the investigation of chronic diarrhoea and disclose a rare diagnosis of sprue-like enteropathy olmesartan-induced. According to the European definition of general practice/family medicine, the FD is responsible for the longitudinal continuity of care which will involve the reassessment and monitoring of the clinical condition. Furthermore, once faced with this diagnosis, FD is encouraged to overcome the challenge of ulterior blood pressure control.
id RCAP_1f5759c78d48b31f9de3914f820e75dd
oai_identifier_str oai:ojs.rpmgf.pt:article/13360
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling A rare cause of diarrhoea: uncommon effect of an ordinary medicationUma causa rara de diarreia: efeito pouco frequente de um medicamento comumDiarreiaHipertensão arterialAntagonistas dos recetores da angiotensina IIOlmesartanEfeitos adversosDiarrhoeaArterial hypertensionAngiotensin II receptor blockersOlmesartanAdverse effectsIntroduction: Arterial hypertension is a chronic condition and one of the main risk factors for cardiovascular disease. Therefore, patients presenting with this disorder benefit from regular follow-ups with their general practitioner/family doctor (FD). Blood pressure control can be achieved with lifestyle measures alone or by resorting simultaneously to pharmacological treatment. Among pharmacological options, angiotensin II receptor blockers (ARB) stand out for being commonly used due to their anti-hypertensive effect and safety profile, albeit they can rarely cause severe chronic diarrhoea. This case report intends to present a rare diagnosis and sharpen FD to a new diagnostic hypothesis in the face of chronic diarrhoea. Case report: A 65-year-old woman, with a personal history of arterial hypertension treated with olmesartan 20mg since 2012 and no other relevant personal history. The patient presented with a one-month history of diarrhoea entailing several medical evaluations. Along with abdominal pain, nausea, vomiting, asthenia, and weight loss. Due to an inconclusive outpatient investigation and lack of clinical response to the multiple empirical treatments, the patient was proposed for hospital admission for further etiological study. While hospitalized, olmesartan was discontinued resulting in symptom resolution, which lead to patient discharge with the diagnosis of sprue-like enteropathy. Conclusion: This case intends to emphasize the importance of a complete and detailed medical history, recall the main steps in the investigation of chronic diarrhoea and disclose a rare diagnosis of sprue-like enteropathy olmesartan-induced. According to the European definition of general practice/family medicine, the FD is responsible for the longitudinal continuity of care which will involve the reassessment and monitoring of the clinical condition. Furthermore, once faced with this diagnosis, FD is encouraged to overcome the challenge of ulterior blood pressure control.Introdução: A hipertensão arterial (HTA) é uma doença crónica e um dos principais fatores de risco para doenças cardiovasculares. Por essa razão, o doente hipertenso beneficia de um seguimento regular e orientado pelo seu médico de família (MF). O controlo tensional pode ser alcançado com medidas de estilo de vida ou também com recurso a terapêutica farmacológica. Desta última, salienta-se a classe dos antagonistas do recetor da angiotensina II (ARA), comummente utilizados na prática clínica pelo seu efeito anti-hipertensivo e perfil de segurança, sendo que em raras vezes pode causar diarreia crónica grave. O presente relato pretende dar a conhecer um diagnóstico raro e sensibilizar o MF para uma nova hipótese diagnóstica perante um quadro de diarreia crónica. Descrição do caso: Mulher, 65 anos, com antecedentes pessoais de HTA medicada com olmesartan 20mg desde 2012, sem outros antecedentes pessoais de relevo. A doente iniciou um quadro de diarreia com um mês de evolução e que motivou inúmeras avaliações médicas. Associadamente, com queixas de cólica abdominal, náusea, vómitos, astenia e perda ponderal. Perante uma investigação em ambulatório inconclusiva e à ausência de melhoria clínica com os diversos tratamentos empíricos, a utente foi proposta para internamento para estudo etiológico. Ao longo do internamento, a descontinuação do olmesartan resultou na resolução do quadro, tendo tido alta com o diagnóstico de enteropatia sprue-like. Comentário: O presente caso pretende enfatizar a importância de uma anamnese completa e detalhada, relembrar os principais passos no estudo da diarreia crónica e dar a conhecer um diagnóstico raro de enteropatia sprue-like induzida pelo olmesartan. Em concordância com as características da disciplina de medicina geral e familiar, caberá ao MF o acompanhamento longitudinal destes utentes, com consequente reavaliação e vigilância das queixas. Perante este diagnóstico levanta-se um novo desafio ao MF na ulterior orientação do controlo tensional destes utentes.Associação Portuguesa de Medicina Geral e Familiar2022-11-09info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.32385/rpmgf.v38i5.13360https://doi.org/10.32385/rpmgf.v38i5.13360Portuguese Journal of Family Medicine and General Practice; Vol. 38 No. 5 (2022): Revista Portuguesa de Medicina Geral e Familiar; 524-9Revista Portuguesa de Medicina Geral e Familiar; Vol. 38 Núm. 5 (2022): Revista Portuguesa de Medicina Geral e Familiar; 524-9Revista Portuguesa de Medicina Geral e Familiar; Vol. 38 N.º 5 (2022): Revista Portuguesa de Medicina Geral e Familiar; 524-92182-51812182-517310.32385/rpmgf.v38i5reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPporhttps://rpmgf.pt/ojs/index.php/rpmgf/article/view/13360https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13360/11812Direitos de Autor (c) 2022 Revista Portuguesa de Medicina Geral e Familiarinfo:eu-repo/semantics/openAccessCosta, RafaelaCunha, Maria João2024-09-17T12:00:32Zoai:ojs.rpmgf.pt:article/13360Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T18:52:48.385116Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv A rare cause of diarrhoea: uncommon effect of an ordinary medication
Uma causa rara de diarreia: efeito pouco frequente de um medicamento comum
title A rare cause of diarrhoea: uncommon effect of an ordinary medication
spellingShingle A rare cause of diarrhoea: uncommon effect of an ordinary medication
Costa, Rafaela
Diarreia
Hipertensão arterial
Antagonistas dos recetores da angiotensina II
Olmesartan
Efeitos adversos
Diarrhoea
Arterial hypertension
Angiotensin II receptor blockers
Olmesartan
Adverse effects
title_short A rare cause of diarrhoea: uncommon effect of an ordinary medication
title_full A rare cause of diarrhoea: uncommon effect of an ordinary medication
title_fullStr A rare cause of diarrhoea: uncommon effect of an ordinary medication
title_full_unstemmed A rare cause of diarrhoea: uncommon effect of an ordinary medication
title_sort A rare cause of diarrhoea: uncommon effect of an ordinary medication
author Costa, Rafaela
author_facet Costa, Rafaela
Cunha, Maria João
author_role author
author2 Cunha, Maria João
author2_role author
dc.contributor.author.fl_str_mv Costa, Rafaela
Cunha, Maria João
dc.subject.por.fl_str_mv Diarreia
Hipertensão arterial
Antagonistas dos recetores da angiotensina II
Olmesartan
Efeitos adversos
Diarrhoea
Arterial hypertension
Angiotensin II receptor blockers
Olmesartan
Adverse effects
topic Diarreia
Hipertensão arterial
Antagonistas dos recetores da angiotensina II
Olmesartan
Efeitos adversos
Diarrhoea
Arterial hypertension
Angiotensin II receptor blockers
Olmesartan
Adverse effects
description Introduction: Arterial hypertension is a chronic condition and one of the main risk factors for cardiovascular disease. Therefore, patients presenting with this disorder benefit from regular follow-ups with their general practitioner/family doctor (FD). Blood pressure control can be achieved with lifestyle measures alone or by resorting simultaneously to pharmacological treatment. Among pharmacological options, angiotensin II receptor blockers (ARB) stand out for being commonly used due to their anti-hypertensive effect and safety profile, albeit they can rarely cause severe chronic diarrhoea. This case report intends to present a rare diagnosis and sharpen FD to a new diagnostic hypothesis in the face of chronic diarrhoea. Case report: A 65-year-old woman, with a personal history of arterial hypertension treated with olmesartan 20mg since 2012 and no other relevant personal history. The patient presented with a one-month history of diarrhoea entailing several medical evaluations. Along with abdominal pain, nausea, vomiting, asthenia, and weight loss. Due to an inconclusive outpatient investigation and lack of clinical response to the multiple empirical treatments, the patient was proposed for hospital admission for further etiological study. While hospitalized, olmesartan was discontinued resulting in symptom resolution, which lead to patient discharge with the diagnosis of sprue-like enteropathy. Conclusion: This case intends to emphasize the importance of a complete and detailed medical history, recall the main steps in the investigation of chronic diarrhoea and disclose a rare diagnosis of sprue-like enteropathy olmesartan-induced. According to the European definition of general practice/family medicine, the FD is responsible for the longitudinal continuity of care which will involve the reassessment and monitoring of the clinical condition. Furthermore, once faced with this diagnosis, FD is encouraged to overcome the challenge of ulterior blood pressure control.
publishDate 2022
dc.date.none.fl_str_mv 2022-11-09
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.32385/rpmgf.v38i5.13360
https://doi.org/10.32385/rpmgf.v38i5.13360
url https://doi.org/10.32385/rpmgf.v38i5.13360
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13360
https://rpmgf.pt/ojs/index.php/rpmgf/article/view/13360/11812
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2022 Revista Portuguesa de Medicina Geral e Familiar
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2022 Revista Portuguesa de Medicina Geral e Familiar
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Associação Portuguesa de Medicina Geral e Familiar
publisher.none.fl_str_mv Associação Portuguesa de Medicina Geral e Familiar
dc.source.none.fl_str_mv Portuguese Journal of Family Medicine and General Practice; Vol. 38 No. 5 (2022): Revista Portuguesa de Medicina Geral e Familiar; 524-9
Revista Portuguesa de Medicina Geral e Familiar; Vol. 38 Núm. 5 (2022): Revista Portuguesa de Medicina Geral e Familiar; 524-9
Revista Portuguesa de Medicina Geral e Familiar; Vol. 38 N.º 5 (2022): Revista Portuguesa de Medicina Geral e Familiar; 524-9
2182-5181
2182-5173
10.32385/rpmgf.v38i5
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833597726084825088